US Senate aims to attach major marijuana legislation to end-of-year 'must-pass' bills.
Yes, and the high of the day is coming up again...25 minutes left to find out.
That is a good signal
Yes, nice recovery from this morning and it's trading just over 85% of its 10-day average volume in the last hour of the day.
Completely agree with your assessment...
Flora Growth is an internationally focused cannabis company that leverages natural, low-cost cultivation practices to supply cannabis derivatives to its diverse business divisions.
We strive to exceed the expectations of customers across the globe. We develop products to positively impact the health and wellness of people. From pharmaceuticals to consumer products, we strive to help people restore and thrive.
What makes Flora such a compelling and unique company is the fact that they have tossed their net far and wide. While many cann-a-bis companies rely heavily on the sometimes-lumbering approval processes in Canada and the United States, Flora is playing it smart by planting their seeds in the global marketplace as well.
Chart ready to bounce https://www.stockscores.com/chart.asp?TickerSymbol=FLGC&TimeRange=1300&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=&avgType2=SMA&movAvg2=&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
A growing sector for sure FLGC
The spread is tight here now FLGC
After $1.78, it thins out a lot...
The company will produce and distribute branded cann-a-bis beverages sporting the Tonino Lamborghini brand across North America and Colombia.
The products will be produced in Florida initially for sale in US states where C-B-D ingestible are legal.
The market for C-B-D products is projected to grow into a $20 billion opportunity by 2024, and the growth of that market is expected to largely come from beverages and edibles.
This is trading less than half of its 10-day average volume but holding steady near green...
Analysts believe that Flora Growth Corp. (NASDAQ: FLGC) stock could be surprisingly undervalued with a 5x upside potential, according to TipRank
Flora Pharma is launching a study on the use of cann-a-binoids in patients suffering from Fibromyalgia or chronic pain, with the primary research sites located in the United States and the United Kingdom.
This game-changing research is headed by Flora’s Dr. Annabelle Morgan-Manalo.?
Dr. Annabelle, as she is known, is a cell and developmental biologist from Vanderbilt University, with a background in neuroscience from Georgetown University. She earned her PhD in Cell and Developmental Biology with a focus in Cardio-Oncology and has since become a philanthropist and entrepreneur focused on pharmaceutical innovation and clinical trial research in medical cann-a-bis.?
30 minutes left in the day, let's see what happens next...
Volume closing in on the 10-day average volume... Nice green day regardless.